HOP Sud Francilien

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Coronary artery disease
• Heart failure

Closed trials

• Completed

  EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)

  NCT04509674· Phase 3· Boehringer Ingelheim· Source